The key findings provide the most reliable timeline for expected results: Week 4: Average weight loss of approximately 1 to 2% of body weight Week 12: Average weight loss of approximately 5 to 6% of body weight Week 20: Average weight loss of approximately 10% of body weight Week 40: Average weight loss of approximately 13 to 14% of body weight Week 68: Average weight loss of approximately 15 to 17% of body weight These are averages, meaning some participants lost more and some lost less
We will do our absolute best to respond within 24 hours of receiving your email
Head-to-head trial result SURMOUNT-5 found tirzepatide produced about 20% average body weight loss versus roughly 14% for semaglutide over 72 weeks in adults with obesity
Across the Phase 3 TRIUMPH-2 and TRIUMPH-3 trials, Lillys investigational triple agonist delivered up to 22.6% mean weight loss at 80 weeks, alongside robust glycaemic improvement and broad cardiometabolic risk-factor reductions
Glutamate is stored mainly in neuronal vesicles prepared for its neurotransmitter function, however, a significant proportion of glutamate is oxidatively metabolized by conversion to oxoglutarate to the tricarboxylic acid cycle (TCA) in neurons (Hassel 2001), as well as glial cells (Gond et al
however, the coefficients for all variables (both case and control) were not statistically significant, suggesting that these demographic factors do not have a meaningful impact on WL in this context